vs
FENNEC PHARMACEUTICALS INC.（FENC）与RIVERVIEW BANCORP INC（RVSB）财务数据对比。点击上方公司名可切换其他公司
RIVERVIEW BANCORP INC的季度营收约是FENNEC PHARMACEUTICALS INC.的1.0倍（$14.0M vs $13.8M），RIVERVIEW BANCORP INC净利率更高（9.8% vs -34.7%，领先44.5%），FENNEC PHARMACEUTICALS INC.同比增速更快（73.8% vs 10.4%），过去两年RIVERVIEW BANCORP INC的营收复合增速更高（24.6% vs -26.3%）
Fennec制药是一家生物制药企业，专注于开发和商业化可降低儿童癌症患者治疗相关副作用的特种疗法，核心产品针对化疗引发的耳毒性，主要市场覆盖北美，服务肿瘤诊疗机构及儿童肿瘤患者群体。
Riverview Bancorp Inc.是一家总部位于美国的银行控股公司，主营个人与商业银行业务，服务覆盖太平洋西北地区，提供存款、消费贷款、住房抵押贷款、商业信贷及小企业金融等产品，服务零售客户与本地企业群体。
FENC vs RVSB — 直观对比
营收规模更大
RVSB
是对方的1.0倍
$13.8M
营收增速更快
FENC
高出63.5%
10.4%
净利率更高
RVSB
高出44.5%
-34.7%
两年增速更快
RVSB
近两年复合增速
-26.3%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $13.8M | $14.0M |
| 净利润 | $-4.8M | $1.4M |
| 毛利率 | — | — |
| 营业利润率 | -18.5% | 12.4% |
| 净利率 | -34.7% | 9.8% |
| 营收同比 | 73.8% | 10.4% |
| 净利润同比 | -141.1% | 11.8% |
| 每股收益（稀释后） | $-0.17 | $0.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FENCRVSB
| Q4 25 | $13.8M | $14.0M | ||
| Q3 25 | $12.5M | $13.6M | ||
| Q2 25 | $9.7M | $13.3M | ||
| Q1 25 | $8.8M | $12.9M | ||
| Q4 24 | $7.9M | $12.7M | ||
| Q3 24 | $7.0M | $12.8M | ||
| Q2 24 | $7.3M | $12.2M | ||
| Q1 24 | $25.4M | $9.0M |
净利润FENCRVSB
| Q4 25 | $-4.8M | $1.4M | ||
| Q3 25 | $-638.0K | $1.1M | ||
| Q2 25 | $-3.2M | $1.2M | ||
| Q1 25 | $-1.2M | $1.1M | ||
| Q4 24 | $-2.0M | $1.2M | ||
| Q3 24 | $-5.7M | $1.6M | ||
| Q2 24 | $-5.6M | $966.0K | ||
| Q1 24 | $12.8M | $-3.0M |
营业利润率FENCRVSB
| Q4 25 | -18.5% | 12.4% | ||
| Q3 25 | -1.5% | 10.2% | ||
| Q2 25 | -28.3% | 11.7% | ||
| Q1 25 | -9.2% | 11.3% | ||
| Q4 24 | -11.8% | 12.4% | ||
| Q3 24 | -74.6% | 15.5% | ||
| Q2 24 | -69.4% | 10.0% | ||
| Q1 24 | 54.2% | -47.5% |
净利率FENCRVSB
| Q4 25 | -34.7% | 9.8% | ||
| Q3 25 | -5.1% | 8.1% | ||
| Q2 25 | -32.7% | 9.2% | ||
| Q1 25 | -13.3% | 8.9% | ||
| Q4 24 | -25.0% | 9.7% | ||
| Q3 24 | -82.2% | 12.2% | ||
| Q2 24 | -76.5% | 7.9% | ||
| Q1 24 | 50.6% | -34.7% |
每股收益（稀释后）FENCRVSB
| Q4 25 | $-0.17 | $0.07 | ||
| Q3 25 | $-0.02 | $0.05 | ||
| Q2 25 | $-0.11 | $0.06 | ||
| Q1 25 | $-0.04 | $0.05 | ||
| Q4 24 | $-0.02 | $0.06 | ||
| Q3 24 | $-0.21 | $0.07 | ||
| Q2 24 | $-0.20 | $0.05 | ||
| Q1 24 | $0.41 | $-0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $36.8M | $28.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $35.5M | $164.2M |
| 总资产 | $70.6M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FENCRVSB
| Q4 25 | $36.8M | $28.6M | ||
| Q3 25 | $21.9M | $32.8M | ||
| Q2 25 | $18.7M | $34.2M | ||
| Q1 25 | $22.7M | $29.4M | ||
| Q4 24 | $26.6M | $25.3M | ||
| Q3 24 | $40.3M | $31.0M | ||
| Q2 24 | $43.1M | $27.8M | ||
| Q1 24 | $51.2M | $23.6M |
总债务FENCRVSB
| Q4 25 | — | — | ||
| Q3 25 | $19.4M | — | ||
| Q2 25 | $19.4M | — | ||
| Q1 25 | $19.4M | — | ||
| Q4 24 | $19.3M | — | ||
| Q3 24 | $32.1M | — | ||
| Q2 24 | $31.8M | — | ||
| Q1 24 | $31.3M | — |
股东权益FENCRVSB
| Q4 25 | $35.5M | $164.2M | ||
| Q3 25 | $-4.5M | $163.5M | ||
| Q2 25 | $-7.5M | $162.0M | ||
| Q1 25 | $-5.9M | $160.0M | ||
| Q4 24 | $-5.9M | $158.3M | ||
| Q3 24 | $-5.2M | $160.8M | ||
| Q2 24 | $-1.4M | $155.9M | ||
| Q1 24 | $3.0M | $155.6M |
总资产FENCRVSB
| Q4 25 | $70.6M | $1.5B | ||
| Q3 25 | $49.3M | $1.5B | ||
| Q2 25 | $44.9M | $1.5B | ||
| Q1 25 | $46.4M | $1.5B | ||
| Q4 24 | $44.9M | $1.5B | ||
| Q3 24 | $58.9M | $1.5B | ||
| Q2 24 | $63.2M | $1.5B | ||
| Q1 24 | $69.2M | $1.5B |
负债/权益比FENCRVSB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 10.40× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-6.0M | $-506.0K |
| 自由现金流经营现金流 - 资本支出 | — | $-736.0K |
| 自由现金流率自由现金流/营收 | — | -5.2% |
| 资本支出强度资本支出/营收 | — | 1.6% |
| 现金转化率经营现金流/净利润 | — | -0.37× |
| 过去12个月自由现金流最近4个季度 | — | $20.4M |
8季度趋势，按日历期对齐
经营现金流FENCRVSB
| Q4 25 | $-6.0M | $-506.0K | ||
| Q3 25 | $1.5M | $16.8M | ||
| Q2 25 | $-3.7M | $-697.0K | ||
| Q1 25 | $-4.3M | $8.3M | ||
| Q4 24 | $-1.5M | $2.2M | ||
| Q3 24 | $-2.2M | $764.0K | ||
| Q2 24 | $-8.4M | $5.4M | ||
| Q1 24 | $39.0M | $12.8M |
自由现金流FENCRVSB
| Q4 25 | — | $-736.0K | ||
| Q3 25 | — | $16.4M | ||
| Q2 25 | — | $-773.0K | ||
| Q1 25 | — | $5.6M | ||
| Q4 24 | — | $1.9M | ||
| Q3 24 | — | $-1.4M | ||
| Q2 24 | — | $5.3M | ||
| Q1 24 | — | $7.1M |
自由现金流率FENCRVSB
| Q4 25 | — | -5.2% | ||
| Q3 25 | — | 120.1% | ||
| Q2 25 | — | -5.8% | ||
| Q1 25 | — | 43.1% | ||
| Q4 24 | — | 15.0% | ||
| Q3 24 | — | -11.3% | ||
| Q2 24 | — | 43.7% | ||
| Q1 24 | — | 79.0% |
资本支出强度FENCRVSB
| Q4 25 | — | 1.6% | ||
| Q3 25 | — | 2.9% | ||
| Q2 25 | — | 0.6% | ||
| Q1 25 | — | 21.0% | ||
| Q4 24 | — | 2.4% | ||
| Q3 24 | — | 17.3% | ||
| Q2 24 | — | 0.9% | ||
| Q1 24 | — | 62.0% |
现金转化率FENCRVSB
| Q4 25 | — | -0.37× | ||
| Q3 25 | — | 15.25× | ||
| Q2 25 | — | -0.57× | ||
| Q1 25 | — | 7.20× | ||
| Q4 24 | — | 1.79× | ||
| Q3 24 | — | 0.49× | ||
| Q2 24 | — | 5.63× | ||
| Q1 24 | 3.04× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
